| 000 | 01894 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517061444.0 | ||
| 264 | 0 | _c20161005 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2015.10.072 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCross, Alan S | |
| 245 | 0 | 0 |
_aPhase 1 testing of detoxified LPS/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsis. _h[electronic resource] |
| 260 |
_bVaccine _cNov 2015 |
||
| 300 |
_a6719-26 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 |
_aBacterial Outer Membrane Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aImmunoglobulin M _xblood |
| 650 | 0 | 4 |
_aLipopolysaccharides _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningococcal Infections _xprevention & control |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xadministration & dosage |
| 650 | 0 | 4 |
_aSepsis _xprevention & control |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGreenberg, Nancy | |
| 700 | 1 | _aBillington, Melissa | |
| 700 | 1 | _aZhang, Lei | |
| 700 | 1 | _aDeFilippi, Christopher | |
| 700 | 1 | _aMay, Ryan C | |
| 700 | 1 | _aBajwa, Kanwaldeep K | |
| 773 | 0 |
_tVaccine _gvol. 33 _gno. 48 _gp. 6719-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2015.10.072 _zAvailable from publisher's website |
| 999 |
_c25399815 _d25399815 |
||